Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Multiple Sclerosis in a Clinical Setting

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The primary objective of the study is to validate the safety and performance of the ABLE Exoskeleton device in people with multiple sclerosis during a 10-session gait training program in a clinical setting. Furthermore, the potential effects of the training on walking, and balance function, general health status, user satisfaction, and quality of life will be assessed.
Epistemonikos ID: 94ad0bb5668de10c022d80397f780d83610a4279
First added on: May 15, 2024